CLSD – clearside biomedical, inc. (US:NASDAQ)
Stock Stats
News
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy [Yahoo! Finance]
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Form 10-Q Clearside Biomedical, For: Sep 30
Form 8-K Clearside Biomedical, For: Nov 12
Form 4 Clearside Biomedical, For: Nov 01 Filed by: Chong Ngai Hang Victor
Form 8-K Clearside Biomedical, For: Oct 09
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.